About Lumen
Lumen is a company based in Ramat Hasharon (Israel) founded in 2014 by Merav Mor, Avi Smila, Michal Mor, Daniel Tal, and Dror Ceder. It operates as a Direct-to-Consumer (D2C). Lumen has raised $77.5 million across 4 funding rounds from investors including Hanwha, H&H Group and Pitango. Lumen offers products and services including Lumen Device. Lumen operates in a competitive market with competitors including Tyto Care, Endotronix, Edwards Lifesciences, BioIntelliSense and Oxehealth, among others.
- Headquarter Ramat Hasharon, Israel
- Founders Merav Mor, Avi Smila, Michal Mor, Daniel Tal, Dror Ceder
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Metaflow Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$77.5 M (USD)
in 4 rounds
-
Latest Funding Round
$62 M (USD), Series B
Dec 01, 2022
-
Investors
Hanwha
& 13 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lumen
Lumen offers a comprehensive portfolio of products and services, including Lumen Device.
A handheld device measuring metabolism through breath analysis.
People of Lumen
Unlock access to complete
Funding Insights of Lumen
Lumen has successfully raised a total of $77.5M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $62 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $62.0M
- First Round First Round
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Series B - Lumen | Valuation | Pitango | |
| Sep, 2019 | Amount | Series B - Lumen | Valuation | H&H Group , Unorthodox Ventures | |
| Jul, 2018 | Amount | Series A - Lumen | Valuation | Resolute Ventures , Red Swan Ventures |
Investors in Lumen
Lumen has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Hanwha, H&H Group and Pitango.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in tech and healthtech sectors through dedicated funds.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital funding is provided to founders.
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by RiverPark Funds group
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lumen
Financial Statements - Lumen
Lumen Comparisons
Competitors of Lumen
Lumen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, Endotronix, Edwards Lifesciences, BioIntelliSense and Oxehealth, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
Medical devices for structural heart disease are developed and provided.
|
|
| domain | founded_year | HQ Location |
Vital signs are monitored via a single-use patch and platform.
|
|
| domain | founded_year | HQ Location |
Contactless patient monitoring is provided for mental health facilities.
|
|
| domain | founded_year | HQ Location |
Remote monitoring platform for tracking patient activity
|
Frequently Asked Questions about Lumen
Lumen was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Lumen is headquartered in Ramat Hasharon, Israel. It is registered at Ramat Hasharon, Tel Aviv District, Israel.
Daniel Tal is the current CEO of Lumen. They have also founded this company.
Lumen is a funded company, having raised a total of $77.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $7M, raised on Nov 01, 2017.
Lumen is known for creating the worlds first handheld metabolic coach, focusing on real-time metabolism tracking through breath analysis. Solutions are provided for improving nutrition, exercise, sleep, and stress levels. The company collaborates with top institutions for innovative research in metabolic health. Services are tailored for individuals seeking weight management, energy boosts, and overall wellness. Data-driven insights are offered to both practitioners and patients in the healthcare sector.
Lumen's top competitors include Tyto Care, Endotronix and Oxehealth.
Lumen offers Lumen Device.
Lumen has 14 investors. Key investors include Hanwha, H&H Group, Pitango, Resolute Ventures, and RiverPark Ventures.